These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24100878)

  • 1. Treatment optimization: an outline for future success.
    Flexner C; Plumley B; Brown Ripin DH
    Curr Opin HIV AIDS; 2013 Nov; 8(6):523-7. PubMed ID: 24100878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization and simplification of antiretroviral therapy for adults and children.
    Ford N; Flexner C; Vella S; Ripin D; Vitoria M
    Curr Opin HIV AIDS; 2013 Nov; 8(6):591-9. PubMed ID: 24100871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral therapy in treatment-naïve patients with HIV infection.
    Camacho R; Teófilo E
    Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S3-11. PubMed ID: 22156777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing HIV treatment programs.
    Bautista-Arredondo S; Martz TE; Wirtz VJ; Bertozzi SM
    Curr Opin HIV AIDS; 2010 May; 5(3):232-6. PubMed ID: 20539079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of HIV treatment guidelines: current state-of-the-art of ART.
    Zolopa AR
    Antiviral Res; 2010 Jan; 85(1):241-4. PubMed ID: 19883695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of antiretroviral therapy: challenges and needs.
    Moreno S; López Aldeguer J; Arribas JR; Domingo P; Iribarren JA; Ribera E; Rivero A; Pulido F;
    J Antimicrob Chemother; 2010 May; 65(5):827-35. PubMed ID: 20228080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reformulation of existing antiretroviral drugs.
    Gogtay JA; Malhotra G
    Curr Opin HIV AIDS; 2013 Nov; 8(6):550-5. PubMed ID: 24100875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvements in antiretroviral therapy outcomes over calendar time.
    Boyd MA
    Curr Opin HIV AIDS; 2009 May; 4(3):194-9. PubMed ID: 19532050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily highly active antiretroviral therapy for HIV-infected children: safety and efficacy of an efavirenz-containing regimen.
    Scherpbier HJ; Bekker V; Pajkrt D; Jurriaans S; Lange JM; Kuijpers TW
    Pediatrics; 2007 Mar; 119(3):e705-15. PubMed ID: 17308244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abacavir and lamivudine for the treatment of human immunodeficiency virus.
    Rizzardini G; Zucchi P
    Expert Opin Pharmacother; 2011 Sep; 12(13):2129-38. PubMed ID: 21787242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and challenges of antiretroviral research and therapy.
    Esté JA; Cihlar T
    Antiviral Res; 2010 Jan; 85(1):25-33. PubMed ID: 20018390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in antiretroviral treatment and prevention in HIV-infected patients.
    Maltêz F; Doroana M; Branco T; Valente C
    Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S21-30. PubMed ID: 22156776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virologic suppression in treatment-experienced patients after virologic rebound or failure of therapy.
    Sarmento-Castro R; Vasconcelos C; Aguas MJ; Marques R; Oliveira J
    Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S12-20. PubMed ID: 22156775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on antiretroviral therapy in paediatrics.
    Penazzato M; Donà D; Wool PS; Rampon O; Giaquinto C
    Antiviral Res; 2010 Jan; 85(1):266-75. PubMed ID: 19879898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.